ICD-10 Coding for Children's Oncology Group Impairment(C91.00, C91.00A, C91.00B)
Comprehensive guide on ICD-10 coding for cognitive impairment in pediatric oncology, including documentation requirements and coding pitfalls.
Complete code families applicable to Children's Oncology Group Impairment
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C91.00 | Acute lymphoblastic leukemia, not having achieved remission | Use when diagnosing a child with ALL as the primary condition |
|
| G31.84 | Mild cognitive impairment, so stated | Use when cognitive impairment is directly linked to cancer treatment |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutChildren's Oncology Group Impairment
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Children's Oncology Group Impairment.
Failure to document treatment link
Impact
Clinical: Misrepresentation of patient's condition, Regulatory: Potential audit failure, Financial: Loss of reimbursement
Mitigation
Use standardized templates, Regular training on documentation standards
Using R41.9 for unspecified cognitive deficits
Impact
Reimbursement: Potential underpayment due to lack of specificity, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Use G31.84 with supporting documentation
Cognitive impairment coding
Impact
Risk of incorrect coding without proper documentation
Mitigation
Ensure all documentation links cognitive issues to treatment